COMMUNIQUÉS West-GlobeNewswire

-
Precision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center
17/01/2019 - 14:45 -
Teladoc Health Expands Continuum of Services with Addition of Back Care Solution
17/01/2019 - 14:35 -
Microbot Medical Showcases a Working Prototype of its Self-Cleaning Shunt
17/01/2019 - 14:32 -
Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
17/01/2019 - 14:30 -
FSD Pharma & Canntab Rank Among the Top 2018 Cannabis Stocks -- CFN Media
17/01/2019 - 14:30 -
Hemostemix Provides Highlights of 2018 Accomplishments
17/01/2019 - 14:30 -
Agritek Holdings, Inc. Announces December Sales of Approximately 2,000 MD Vapes Units to Florida Market With New White Label Deals for Customized CBD and THC Formulas to Top Colorado and Puerto Rico Retail Dispensaries
17/01/2019 - 14:30 -
Abattis Removed From BCSC Temporary Order
17/01/2019 - 14:27 -
Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results
17/01/2019 - 14:05 -
Healthwise and Docola Partner to Deliver Health Education
17/01/2019 - 14:00 -
Gala Pharmaceutical to Present at World Cbd Expo
17/01/2019 - 14:00 -
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals
17/01/2019 - 14:00 -
RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection
17/01/2019 - 14:00 -
Geron Appoints Vice President, Pharmacovigilance and Drug Safety
17/01/2019 - 14:00 -
Rafael Pharmaceuticals to Present Plan for Phase 3 Trial (AVENGER 500) of devimistat (CPI-613®) in Combination with Modified FOLFIRINOX as a First Line Treatment for Metastatic Pancreatic Cancer at 2019 Gastrointestinal Cancers Symposium
17/01/2019 - 14:00 -
Wellness Matrix Group To Initiate State-of-the-Art Wellness Model Program
17/01/2019 - 14:00 -
Progressive Care Releases Open Letter to Shareholders
17/01/2019 - 14:00 -
Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call
17/01/2019 - 14:00 -
Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President
17/01/2019 - 13:58
Pages